Nutrition in Cancer: Evidence and Equality.


Journal

Advances in radiation oncology
ISSN: 2452-1094
Titre abrégé: Adv Radiat Oncol
Pays: United States
ID NLM: 101677247

Informations de publication

Date de publication:
Historique:
received: 22 03 2020
accepted: 12 05 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

Poor nutrition is highly implicated in the pathogenesis of cancer and affects the survival of patients during and after completion of definitive therapies. Mechanistic evidence accumulated over the last century now firmly places dysregulated cellular energetics within the emerging hallmarks of cancer. Nutritional intervention studies often aim to either enhance treatment effect or treat nutritional deficiencies that portend poor prognoses. Patients living within food priority areas have a high risk of nutritional need and are more likely to develop comorbidities, including diabetes, hypertension, renal disease, and cardiovascular risk factors. Unfortunately, there is currently a paucity of data analyzing the impact of food priority areas on cancer outcomes. Therefore, we performed a review of the literature focusing on the molecular and clinical interplay of cancer and nutrition, the importance of clinical trials in elucidating how to intervene in this setting and the significance of including citizens who live in food priority areas in these future prospective studies. Given the importance of nutrition as an emerging hallmark of cancer, further research must be aimed at directing the optimal nutrition strategy throughout oncologic treatments, including the supplementation of nutritious foods to those that are otherwise unable to attain them.

Identifiants

pubmed: 33083643
doi: 10.1016/j.adro.2020.05.008
pii: S2452-1094(20)30139-1
pmc: PMC7557144
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

817-823

Informations de copyright

© 2020 University of Maryland, School of Medicine.

Références

Int J Cancer. 2007 Aug 15;121(4):856-62
pubmed: 17397032
Crit Rev Food Sci Nutr. 2017 Jul 3;57(10):1999-2008
pubmed: 25692500
Nutrients. 2018 Feb 08;10(2):
pubmed: 29419756
Nutr Cancer. 2020;72(7):1225-1230
pubmed: 31603353
Cancer Res. 2010 Feb 15;70(4):1564-72
pubmed: 20145127
J Neurooncol. 2014 Mar;117(1):125-31
pubmed: 24442482
BMC Res Notes. 2016 Mar 05;9:143
pubmed: 26946138
Prog Cell Cycle Res. 2003;5:527-32
pubmed: 14593747
J Natl Cancer Inst. 1998 Jun 17;90(12):911-5
pubmed: 9637140
Science. 2009 Jul 10;325(5937):201-4
pubmed: 19590001
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
JAMA. 2018 Sep 11;320(10):969-970
pubmed: 30422271
Lung Cancer. 2017 Feb;104:52-57
pubmed: 28213000
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
N Engl J Med. 1987 Jan 1;316(1):22-8
pubmed: 3785347
Nutr J. 2012 Apr 24;11:27
pubmed: 22531478
Ann Oncol. 2017 Feb 1;28(2):400-407
pubmed: 27831506
Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9):
pubmed: 28904075
J Hum Nutr Diet. 2014 Jun;27(3):251-60
pubmed: 24102939
Oncotarget. 2016 Mar 29;7(13):17060-73
pubmed: 26959744
Cancer Res. 1990 Sep 15;50(18):5761-6
pubmed: 2393850
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6127-33
pubmed: 20194732
JAMA. 1999 Mar 10;281(10):914-20
pubmed: 10078488
Cancer Res. 1953 Jul;13(7:1):532-6
pubmed: 13067072
Surg Clin North Am. 2011 Jun;91(3):631-9
pubmed: 21621700
Ecol Food Nutr. 2018 Mar-Apr;57(2):94-108
pubmed: 29283673
Hypertension. 2009 Oct;54(4):751-5
pubmed: 19667248
Nutr Metab (Lond). 2016 Aug 12;13:52
pubmed: 27525031
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1008-1015
pubmed: 28506965
Oncologist. 2020 Feb;25(2):161-169
pubmed: 32043776
J Acad Nutr Diet. 2018 Jan;118(1):74-100.e11
pubmed: 29111090
Exp Diabetes Res. 2012;2012:789174
pubmed: 22701472
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1018-28
pubmed: 27340121
J Clin Oncol. 2015 Jan 1;33(1):90-9
pubmed: 25422490
Cancer Res. 1949 Dec;9(12):724-7
pubmed: 15395906
Semin Cancer Biol. 2015 Dec;35 Suppl:S129-S150
pubmed: 26454069
Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2108-17
pubmed: 23112268
Neurobiol Aging. 1999 Sep-Oct;20(5):479-86
pubmed: 10638521
Clin Cancer Res. 2004 Aug 15;10(16):5622-9
pubmed: 15328205
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Br J Cancer. 2002 May 20;86(10):1615-21
pubmed: 12085212
Physiol Rev. 2009 Apr;89(2):381-410
pubmed: 19342610
Nutrition. 1996 Sep;12(9):653-4
pubmed: 8878181
J Exp Med. 1914 Nov 1;20(5):433-51
pubmed: 19867833
BMC Cancer. 2008 Apr 30;8:122
pubmed: 18447912
J Clin Oncol. 2013 Apr 20;31(12):1539-47
pubmed: 23530101
Lancet. 1998 May 9;351(9113):1393-6
pubmed: 9593409
J Nutr. 2018 Aug 1;148(8):1253-1260
pubmed: 30137481
Ann Oncol. 2017 Sep 1;28(9):2107-2118
pubmed: 28911059
Nature. 2009 Apr 9;458(7239):725-31
pubmed: 19279572
Eur J Pharmacol. 2011 Sep;668 Suppl 1:S87-90
pubmed: 21810420
Am J Kidney Dis. 2017 Jul;70(1):38-47
pubmed: 28215947
J Natl Cancer Inst. 1999 Mar 17;91(6):512-23
pubmed: 10088621
Crit Rev Food Sci Nutr. 2017 Nov 22;57(17):3640-3649
pubmed: 26853923
Lancet. 2020 Mar 7;395(10226):785-794
pubmed: 31492501
Trends Endocrinol Metab. 2014 Jan;25(1):42-52
pubmed: 24140022
Nutr Cancer. 2013;65(3):430-9
pubmed: 23530643
Nutrients. 2017 Sep 26;9(10):
pubmed: 28954418
Lancet Oncol. 2008 Nov;9(11):1039-47
pubmed: 18835745
PLoS One. 2012;7(5):e36197
pubmed: 22563484
Support Care Cancer. 2010 Jul;18(7):837-45
pubmed: 19727846
Head Neck. 2006 Apr;28(4):287-96
pubmed: 16287132
Front Neurosci. 2019 Jan 29;13:5
pubmed: 30760973
Radiat Res. 2017 Jun;187(6):743-754
pubmed: 28437190
PLoS Genet. 2008 Jan;4(1):e13
pubmed: 18225956
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2826-8
pubmed: 16364996
Clin Oncol (R Coll Radiol). 2003 Dec;15(8):443-50
pubmed: 14689999
J Oral Maxillofac Surg. 2013 Nov;71(11):1853-60
pubmed: 23845698
Curr Dev Nutr. 2017 Oct 16;1(11):e001446
pubmed: 29955686
Nutr J. 2004 Oct 20;3:19
pubmed: 15496224
Cell Cycle. 2010 Nov 15;9(22):4474-6
pubmed: 21088487
Oncotarget. 2015 Jul 30;6(21):18545-57
pubmed: 26176887
Sci Transl Med. 2012 Mar 7;4(124):124ra27
pubmed: 22323820
Nutr Metab (Lond). 2011 Jul 27;8(1):54
pubmed: 21794124
Cancer. 2016 Jun 15;122(12):1946-53
pubmed: 27159822
BMC Cancer. 2010 Feb 21;10:50
pubmed: 20170547
Clin Cancer Res. 2013 Jul 15;19(14):3905-13
pubmed: 23743570
Trends Endocrinol Metab. 2018 Apr;29(4):271-280
pubmed: 29463451
Neurooncol Pract. 2015 Sep;2(3):127-136
pubmed: 26649186
CA Cancer J Clin. 2012 Jan-Feb;62(1):30-67
pubmed: 22237782
Support Care Cancer. 2010 Mar;18(3):373-81
pubmed: 19484479
Cancer Res. 1951 Jun;11(6):442-6
pubmed: 14839638
Aging (Albany NY). 2009 Dec 31;1(12):988-1007
pubmed: 20157582
Oncologist. 2013;18(1):97-103
pubmed: 23299773
JNCI Cancer Spectr. 2019 May 22;3(2):pkz034
pubmed: 31360907
Carcinogenesis. 1997 May;18(5):1007-12
pubmed: 9163688
Genes Dev. 2009 Mar 1;23(5):537-48
pubmed: 19270154
Cancer Metab. 2014 Sep 01;2:18
pubmed: 25228990

Auteurs

Christopher P Haskins (CP)

Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland.

Colin E Champ (CE)

Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.

Robert Miller (R)

Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland.

Melissa A L Vyfhuis (MAL)

Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland.

Classifications MeSH